‘Government Decision 1092/2020’ [Published in the Official Monitor of Romania no. 1251 of 17 December 2020.], ‘Government Decision 380/2021’ [Published in the Official Monitor of Romania no. 328 of 31 March 2021.], ‘Government Decision 1017/2021’ [Published in the Official Monitor of Romania no. 935 of 30 September 2021.] and ‘Government Decision 1190/2021’ [Published in the Official Monitor of Romania no. 1081 of 11 November 2021.] provided for the purchase of the medication Remdesivir and of monoclonal antibody medicine for COVID-19 treatment that contains Casirivimab and Imdevimab. The procurement procedures for both medications have been conducted by the Commission on behalf of the Member States within framework contracts [Framework agreement SANTE/2020/C3/048 for Remdivisir and framework agreement SANTE/2020/C3/091 for monoclonal antibody medicine.], as referred to in the request.
Recital 24, Decision_act (EU) 2022/1262
In forcesince 18 Jul 2022